Why Is OPMD Misdiagnosed As Myasthenia Gravis?
At a Glance
OPMD is often misdiagnosed as myasthenia gravis because both cause drooping eyelids and swallowing issues in older adults. However, MG symptoms fluctuate with rest, while OPMD causes constant weakness. A genetic blood test for the PABPN1 mutation is the only way to definitively confirm OPMD.
In this answer
3 sections
Myasthenia gravis (MG) is one of the most common misdiagnoses for people who actually have oculopharyngeal muscular dystrophy (OPMD) [1][2]. This confusion happens because both conditions often start when people are in their 40s, 50s, or 60s, and they share the exact same early symptoms: ptosis (drooping eyelids) and dysphagia (difficulty swallowing) [3][2]. However, while the symptoms look similar on the surface, the two conditions are fundamentally different in how they behave over time, their underlying biology, and how they are definitively diagnosed [1][4].
How the Symptoms Differ
The most helpful clue for telling these two conditions apart is the pattern of how the symptoms appear and change:
- Fluctuating vs. Constant: In myasthenia gravis, muscle weakness typically changes significantly throughout the day. The drooping eyelids and swallowing issues often worsen with activity or tiredness and noticeably improve after resting [5][3]. In contrast, OPMD causes a slow, steady progression of weakness [1][5]. The symptoms do not bounce back with a nap or overnight rest. However, general muscle fatigue at the end of a long day can sometimes make OPMD symptoms feel slightly more pronounced, which can further confuse the diagnosis [3][1].
- Limb Weakness Patterns: Both conditions can eventually affect the arms and legs. In MG, this limb weakness also fluctuates and worsens with use [3]. In OPMD, limb weakness typically develops much later in the disease course and follows the same slow, constant, progressive pattern as the facial muscles [3][1].
- Response to Medication: Doctors often prescribe acetylcholinesterase inhibitors—like pyridostigmine (Mestinon)—for suspected myasthenia gravis to improve nerve signaling [1]. A person with MG will usually experience a noticeable, temporary improvement in their symptoms [1]. Because OPMD is a disease of the muscle itself, not the nerves, these medications provide little to no benefit [3][1].
Different Underlying Causes
Though they affect similar parts of the body, MG and OPMD have entirely different root causes:
- Autoimmune vs. Genetic: Myasthenia gravis is an autoimmune disorder [6][7]. This means the body’s immune system mistakenly creates antibodies that attack the neuromuscular junction (the space where nerve signals tell muscles to move) [8][2]. OPMD is a genetic disease caused by a specific flaw (the PABPN1 gene mutation) that causes proteins to clump together and damage the muscle fibers themselves over time [7][2][4].
- Family History: Because OPMD is inherited, there is often a history of older family members who had drooping eyelids or swallowing problems [2][9]. Myasthenia gravis is an autoimmune condition that is not inherited in this same predictable, generational pattern [6][7].
How Doctors Confirm the Diagnosis
If your doctor suspects you might have myasthenia gravis but you are not responding to treatment, or if your blood tests for MG are negative, it is important to look deeper [1][3].
- Blood Tests: MG is typically diagnosed by finding specific auto-antibodies in the blood, like anti-AChR or anti-MuSK [10][8]. If these tests are negative (called “seronegative MG”), OPMD should be heavily considered [2][3].
- Nerve and Muscle Tests: Doctors often use electromyography (EMG) and specialized techniques like single-fiber EMG (SFEMG) or repetitive nerve stimulation (RNS) to test muscle function. In MG, these tests show that the nerve signal is failing to reach the muscle [3]. In OPMD, the tests show that the muscle tissue itself is diseased (a myopathy) [3]. However, findings from SFEMG and RNS can sometimes be misinterpreted by doctors as a nerve signaling problem, leading to a false MG diagnosis in people who actually have a chronic muscle disease like OPMD [3][2].
- The Definitive Test: The only way to absolutely confirm an OPMD diagnosis and separate it from myasthenia gravis is a genetic blood test [10][9]. This test specifically looks for the PABPN1 gene mutation and will rule out or confirm OPMD with certainty [4][2]. Once OPMD is confirmed, your care team can shift focus away from MG medications and toward appropriate symptom management [1].
Common questions in this guide
Why do doctors confuse OPMD and myasthenia gravis?
How can you tell the difference between OPMD and myasthenia gravis symptoms?
What is the main biological difference between OPMD and myasthenia gravis?
What does it mean if my myasthenia gravis medication isn't working?
What is the definitive test to confirm OPMD?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since my symptoms are constant and don't seem to noticeably fluctuate throughout the day, could my diagnosis actually be OPMD instead of Myasthenia Gravis?
- 2.If my blood tests for Myasthenia Gravis antibodies came back negative, should we order a genetic test for the PABPN1 mutation to check for OPMD?
- 3.How much experience does this clinic have in differentiating between genetic myopathies and autoimmune neuromuscular junction disorders?
- 4.Can we review my EMG and nerve stimulation results again to ensure they specifically point to a nerve transmission issue rather than a primary muscle tissue disease?
- 5.Since my trial of acetylcholinesterase inhibitors (like Mestinon) hasn't significantly improved my symptoms, what is our next step in the diagnostic process?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (10)
- 1
Oculopharyngeal muscular dystrophy misdiagnosed as myasthenia gravis: Case report and review of literature.
Aryani O, Akbari M, Aghsaei-Fard M, et al.
Iranian journal of neurology 2017; (16(2)):98-99.
PMID: 28761633 - 2
Oculopharyngeal muscular dystrophy, myasthenia gravis, systemic lupus erythematosus: overlap and interactions.
M Barbosa J, A Pereira P
BMJ case reports 2024; (17(11)) doi:10.1136/bcr-2024-262742.
PMID: 39532331 - 3
Oculopharyngeal Muscular Dystrophy in Singapore: Not So Rare.
Saini M, Tan NC, Chai J
Annals of the Academy of Medicine, Singapore 2018; (47(8)):349-352.
PMID: 30242302 - 4
[Haplotype Analysis of Oculopharyngeal Muscular Dystrophy (OPMD) Locus in Yakutia].
Marusin AV, Kurtanov KhA, Maksimova NR, et al.
Genetika 2016; (52(3)):376-84.
PMID: 27281858 - 5
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD).
Harish P, Malerba A, Lu-Nguyen N, et al.
Journal of cachexia, sarcopenia and muscle 2019; (10(5)):1016-1026 doi:10.1002/jcsm.12438.
PMID: 31066242 - 6
Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy.
Doki T, Yamashita S, Wei FY, et al.
Laboratory investigation; a journal of technical methods and pathology 2019; (99(11)):1728-1740 doi:10.1038/s41374-019-0243-8.
PMID: 30894671 - 7
Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics.
Mezzell AT, Zhang Y, Perez AM, Vest KE
PLoS genetics 2026; (22(1)):e1011743 doi:10.1371/journal.pgen.1011743.
PMID: 41587185 - 8
Oculopharyngeal muscular dystrophy coexisting with myasthenia gravis.
Alungulese AL, García Soldevilla MA, Gordo Mañas R, Vidal Díaz MB
Practical neurology 2022; doi:10.1136/practneurol-2022-003429.
PMID: 35534195 - 9
Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy.
Galimberti V, Tironi R, Lerario A, et al.
European journal of neurology 2020; (27(4)):709-715 doi:10.1111/ene.14131.
PMID: 31769567 - 10
Recurrent Pneumonia in a Patient With Oculopharyngeal Muscular Dystrophy (OPMD) due to GCN Expansion in the PABPN1 Gene: A Diagnostic Challenge.
Mañana Valdés C, Arias Guillén M, Moris de la Tassa G
Open respiratory archives 2026; (8(2)):100580 doi:10.1016/j.opresp.2026.100580.
PMID: 41676387
This page explains the diagnostic differences between OPMD and Myasthenia Gravis for educational purposes. It does not replace professional medical advice. Always consult your neurologist regarding your specific diagnosis and symptoms.
Get notified when new evidence is published on Oculopharyngeal muscular dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.